Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached

Bibliographic Details
Main Author: Massimo Breccia
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020300213